Cargando…

Classical versus new prognostic factors for adjuvant treatment selection based on line software to estimate risk and benefit

Detalles Bibliográficos
Autor principal:	Ravdin, PM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231904/ http://dx.doi.org/10.1186/bcr1224

Ejemplares similares

Adjuvant chemotherapy for operable breast cancer: old vs new schema
por: Valagussa, P, et al.
Publicado: (2005)

Estimating the window of selection of antimalarial drugs using field data
por: Winter, Katherine, et al.
Publicado: (2012)

A new RSC brace design to treat single long thoracic scoliosis. Comparison of the in-brace correction in two groups treated with the new and the classical models
por: Rigo, M, et al.
Publicado: (2009)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Rationale for adjuvant measures in musculoskeletal diseases
por: Gast, Ulf
Publicado: (2013)

OSSE – open source registry software solution
por: Muscholl, Marita, et al.
Publicado: (2014)

Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
por: Choodari-Oskooei, Babak, et al.
Publicado: (2013)

Virus discovery in sandflies, from field studies to phylogenetic tree building: classic methods versus novel methods, what do we need to address public health impact?
por: Bichaud, L, et al.
Publicado: (2014)

Adjuvant therapy of HER2(+ )breast cancer
por: Winer, EP
Publicado: (2009)

Controversies in hormonal adjuvant therapy for premenopausal patients
por: Howell, A
Publicado: (2009)

Controversies in the hormonal adjuvant therapy of postmenopausal patients
por: Dowsett, M
Publicado: (2009)

Bisphosphonates in the adjuvant treatment of early breast cancer
por: Gnant, M
Publicado: (2009)

Palliative versus corrective surgery in new cardiac programs
por: Fenton, K, et al.
Publicado: (2013)

Adjuvant therapy in colorectal cancer – studies of the FOGT group
por: Staib, Ludger, et al.
Publicado: (2010)

Adjuvant therapy after preoperative treatment for breast cancer
por: Ciruelos, E
Publicado: (2009)

Irisin and the therapeutic benefits of exercise
por: Spiegelman, Bruce M, et al.
Publicado: (2012)

Sparse coding models demonstrate some non-classical receptive field effects
por: Zhu, Mengchen, et al.
Publicado: (2010)

Extending classic Haddon’s matrix for road safety promotion: toward better applicability
por: Derakhshani, Naser, et al.
Publicado: (2019)

Using alternative programming algorithms and techniques for optimizing performance of the Casemix software
por: Reeza, H, et al.
Publicado: (2012)

Design, implementation, and evaluation of a software for unintentional injuries prevention in children
por: Tayebi, Zahra, et al.
Publicado: (2022)

O064: Validation and assessment of the new surveillance paradigm for ventilator-associated events
por: Van Mourik, MS, et al.
Publicado: (2013)

Etanercept in juvenile idiopathic arthritis: Who will benefit?
por: Otten, MH, et al.
Publicado: (2011)

Packaging free software chemistry programs in Debian GNU/Linux: past, present and future
por: Banck, Michael
Publicado: (2012)

Benefits of early aneurysm surgery: Southern Iran experience
por: Rahmanian, Abdolkarim, et al.
Publicado: (2012)

PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate
por: Ruperto, N, et al.
Publicado: (2013)

Impaired myocardial perfusion on CMR is associated with increased numbers of classical monocytes in STEMI patients treated by primary PCI
por: Robbers, Lourens FHJ, et al.
Publicado: (2011)

A novel mutatioin in the PSTPIP1 gene is associated with an autoinflammatory disease distinct from classical PAPA syndrome
por: Holzinger, D, et al.
Publicado: (2011)

Monophosphoryl Lipid a as an adjuvant for immune therapy? A detailed in vitro comparison to LPS
por: Schülke, Stefan, et al.
Publicado: (2014)

Benefits of non-medical prescribing within an NHS podiatry service
por: Popadiuk, Susan, et al.
Publicado: (2010)

Controversial Issue Session: Brace treatment in infantile scoliosis: benefits
por: Claude de Mauroy, Jean
Publicado: (2012)

Benefits of PDE5 inhibition in patients with diastolic heart failure
por: Guazzi, Marco
Publicado: (2011)

Benefits of combined treatments using antiresorptive agents and cytotoxic drugs
por: Holen, I, et al.
Publicado: (2006)

Developed-developing country partnerships: benefits from South to North?
por: Syed, SB, et al.
Publicado: (2011)

Benefits of using heated egg (HE) in the management of egg allergy
por: Claver, A, et al.
Publicado: (2013)

Health benefits from moderate drinking: a critical review
por: Andreasson, Sven, et al.
Publicado: (2015)

Making sure there's a "give" associated with the "take": producing and using open-source software in big pharma
por: Landrum, Gregory, et al.
Publicado: (2011)

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques
por: Hirao, Lauren, et al.
Publicado: (2006)

Carbohydrate restriction uniquely benefits metabolic syndrome and saturated fat metabolism
por: Volek, Jeff S
Publicado: (2012)

Enriching the evidence base: moving towards full societal costs and benefits
por: Brouwer, Werner
Publicado: (2014)

Benefits from using recycling red blood cells in cardiovascular surgery
por: Almeida, R, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_h7nbr3ang8k8uko0f2o6nq6j17